SARS-CoV-2 nsp13-IN-2
SARS-CoV-2 nsp13-IN-2 (Compound C2) is a SARS-CoV-2 non-structural protein 13 (nsp13) small-molecule inhibitor with an IC50 of 42 μM against nsp13 ssDNA+ ATPase[1].
Product Specifications
CAS Number
[522660-61-3]
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-nsp13-in-2.html
Solubility
10 mM in DMSO
Smiles
CC1=CC=C(C=C1)N/C(N)=N/C2=NC(C=C(CSC3=NC4=C(S3)C=CC=C4)N2)=O
Molecular Formula
C20H18N6OS2
Molecular Weight
422.53
References & Citations
[1]Yazdi AK, et al. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors. ACS Infect Dis. 2022 Jul 13.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1087437-01 0.02 mg (E-Coli)
Recombinant Human Putative UPF0607 protein ENSP00000383783
Ask
View Details 
MBS1087437-02 0.02 mg (Yeast)
Recombinant Human Putative UPF0607 protein ENSP00000383783
Ask
View Details MBS1087437-03 0.1 mg (E-Coli)
Recombinant Human Putative UPF0607 protein ENSP00000383783
Ask
View Details 
MBS1087437-04 0.1 mg (Yeast)
Recombinant Human Putative UPF0607 protein ENSP00000383783
Ask
View Details MBS1087437-05 0.02 mg (Baculovirus)
Recombinant Human Putative UPF0607 protein ENSP00000383783
Ask
View Details MBS1087437-06 0.02 mg (Mammalian-Cell)
Recombinant Human Putative UPF0607 protein ENSP00000383783
Ask
View Details